Latest News

  • Ageing biomarkers may aid Alzheimer’s diagnosis, research suggests

    Ageing biomarkers may aid Alzheimer's diagnosis, with research suggesting they could help distinguish the condition from other brain disorders. Research led by Dr Bryan Ng, Prof Nick Fox and Prof Henrik Zetterberg at the UK DRI at UCL showed that biomarkers linked to ageing are altered in people with Alzheimer's. Alzheimer's is marked by a [...]

  • Yoga ‘may support cardiometabolic health outcomes in overweight adults’

    Yoga may support cardiometabolic health in adults with overweight or obesity, according to a new study. The study examined 30 yoga studies involving 2,689 participants to assess cardiometabolic health, meaning measures linked to heart health and metabolism such as blood pressure, cholesterol and blood sugar. Researchers found that people who practised yoga had lower blood [...]

  • Nasal spray slows brain ageing and restores memory, study finds

    A nasal spray can slow brain ageing, cut brain inflammation and restore memory in two doses, with effects lasting months, according to a new study. Researchers from Texas A&M University in the US said the spray could reshape future therapies for conditions such as Alzheimer's disease, and may even change what is known about brain [...]

  • Menopause brain fog and dementia risk: What the 2026 evidence really shows

    Article produced in association with Spital Clinic Few health worries are as common in midlife as the question of whether the brain fog that arrives with menopause is a sign of something more serious. Forgotten names, lost words, scattered concentration - and all of it in a decade of life when Alzheimer's disease begins its [...]

  • NHS launches Inherited Cancer Register in 2026: What older adults need to know

    Article produced in association with Jeen Health On 24 January 2026, NHS England launched the NHS National Inherited Cancer Predisposition Register - a programme that will eventually cover around 120 cancer susceptibility genes. For adults over 50, this matters more than it first appears. Cancer risk accelerates with age. Diagnoses in later life - breast, [...]

  • Severe childhood malaria linked to cognitive impairment later in life

    Severe childhood malaria is linked to cognitive harm into adolescence, according to a new study. The findings suggest children who survive cerebral malaria and severe malarial anaemia can experience cognitive and academic impairment that persists later in life. The link points to a need for better prevention strategies and more effective therapies to limit lasting [...]

  • Diabates patients in Wales to receive specialist mental health support in ‘UK first’

    Wales is developing a diabetes mental health pathway to give people faster access to specialist support, in what experts say is a UK first. The model aims to provide more joined-up support for people whose mental health and diabetes management are closely tied together. It follows growing concern that people with diabetes are often passed [...]

  • Agetech investment round-up featuring Life Biosciences, Eli Lilly, L-Nutra & LinkGevity

    Agetech investment round-up featuring Life Biosciences, Eli Lilly, L-Nutra & LinkGevity The first quarter of 2026 has been a record one in healthy-ageing finance with some US$3.74bn of investment across 49 deals - an increase of 56% in total financing against the same period last year And, the second quarter has gotten off to a [...]

  • Agetech research roundup – featuring Dr David Sinclair and Shinya Yamanaka

    Leading healthy-ageing scientist Dr David Sinclair is using AI to build a pill that reverses ageing with a targeted price of US$100. Explaining the science behind these developments Dr Sinclair says all human cells carry the same DNA, with the determination of their exact role being a function of the cell overlord - the epigenome [...]

  • US Alzheimer’s drug pioneer Anavex presses-on, despite regulatory setback

    Alzheimer’s drug pioneer Anavex is pressing ahead with plans to secure approval for its ground-breaking treatment despite a recent setback. Earlier this year it lodged an appeal against the European Medicines Agency (EMA) decision to reject its application for drug approval in December 2025. But, Anavex has now withdrawn this appeal as it seeks to [...]